Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-04-30 Net Asset Value
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is very short (247 characters) and is titled 'Fondsbørsmeddelelse' (Stock Exchange Announcement). The content explicitly states the 'Indre værdi' (Net Asset Value or NAV) calculated for a specific date (April 30, 2009) as 39.09. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-04-30 English
Regulatory Filings 2009
Regulatory Filings
2009-04-29 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (247 characters) and is titled 'Fondsbørsmeddelelse' (Stock Exchange Announcement). The content explicitly states the 'Indre værdi' (Net Asset Value or NAV) calculated for a specific date (April 29, 2009) as 38.88. This directly corresponds to the definition of a Net Asset Value update (NAV). Although it is an announcement, the specific nature of the content (NAV calculation) overrides the general RPA/RNS fallback.
2009-04-29 English
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (247 characters) and is titled "Fondsbørsmeddelelse" (Stock Exchange Announcement). The content explicitly states the calculated 'Indre værdi' (Net Asset Value or NAV) for a specific date (April 28, 2009) as 38.89. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-04-28 English
Regulatory Filings 2009
Regulatory Filings
2009-04-28 Danish
AGM Information 2009
AGM Information Classification · 99% confidence The document is titled "Forløb af ordinær generalforsamling" (Proceedings of the Annual General Meeting) and details the outcomes of a meeting held on April 27, 2009. It explicitly mentions the approval of the annual report, election of board members, appointment of the auditor (KPMG), and the adoption of several shareholder proposals, including authorization for share acquisition and capital increases. This content directly relates to the formal proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The document length is short (1964 chars), but it contains the full substance of the meeting's results, not just an announcement that the meeting occurred or that materials are available.
2009-04-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.